Insider Transactions in Q2 2024 at Standard Biotools Inc. (LAB)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2024
|
Frank Witney |
BUY
Grant, award, or other acquisition
|
Direct |
43,128
+27.06%
|
-
|
|
Jun 28
2024
|
Kathy L Hibbs |
BUY
Grant, award, or other acquisition
|
Direct |
43,128
+50.0%
|
-
|
|
Jun 28
2024
|
Thomas D. Carey |
BUY
Grant, award, or other acquisition
|
Direct |
43,128
+50.0%
|
-
|
|
Jun 28
2024
|
Fenel M Eloi |
BUY
Grant, award, or other acquisition
|
Direct |
43,128
+23.35%
|
-
|
|
Jun 28
2024
|
Eli Casdin |
BUY
Grant, award, or other acquisition
|
Direct |
43,128
+1.54%
|
-
|
|
Jun 28
2024
|
Troy Cox |
BUY
Grant, award, or other acquisition
|
Direct |
43,128
+21.04%
|
-
|
|
Jun 18
2024
|
Casdin Partners Master Fund, L.P. Director |
SELL
Other acquisition or disposition
|
Indirect |
1,200,000
-100.0%
|
$2,400,000
$2.05 P/Share
|
|
Jun 18
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Other acquisition or disposition
|
Indirect |
1,200,000
+25.69%
|
$2,400,000
$2.05 P/Share
|
|
May 23
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.22%
|
$200,000
$2.6 P/Share
|
|
May 22
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
150,000
+0.33%
|
$300,000
$2.58 P/Share
|
|
May 21
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
350,000
+0.76%
|
$700,000
$2.56 P/Share
|
|
May 20
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.22%
|
$200,000
$2.58 P/Share
|
|
May 20
2024
|
Hanjoon Alex Kim Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
333,333
+37.98%
|
-
|
|
May 20
2024
|
Jeffrey G. Black SVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+41.68%
|
-
|
|
May 20
2024
|
Michael Egholm President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,000,000
+39.5%
|
-
|
|
May 17
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
352,072
+0.77%
|
$704,144
$2.56 P/Share
|
|
May 16
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+1.1%
|
$1,000,000
$2.54 P/Share
|
|
May 15
2024
|
Casdin Partners Master Fund, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+1.11%
|
$1,000,000
$2.57 P/Share
|
|
May 15
2024
|
Jeffrey G. Black SVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,779
-13.55%
|
$37,558
$2.54 P/Share
|
|
May 15
2024
|
Jeffrey G. Black SVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
52,631
+27.52%
|
-
|
|
Apr 08
2024
|
Michael Egholm President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
102,564
-16.17%
|
$205,128
$2.71 P/Share
|
|
Apr 05
2024
|
Hanjoon Alex Kim Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,702
+25.09%
|
-
|
|
Apr 05
2024
|
Michael Egholm President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
212,126
+25.07%
|
-
|
|
Apr 04
2024
|
Hanjoon Alex Kim Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,183
+33.33%
|
-
|
|
Apr 04
2024
|
Michael Egholm President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
196,512
+31.77%
|
-
|